Keros Therapeutics, Inc. (KROS)

11.38 +0.06 (+0.57%) USD  |  NASDAQ  |  Apr 22, 15:32
More

Keros Therapeutics Sell Recommendations

Sell Recommendations Chart

View Sell Recommendations for KROS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Sell Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Sell Recommendations Range, Past 5 Years

View Sell Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Sell Recommendations Benchmarks

View Sell Recommendations Benchmarks
Start Trial
Sarepta Therapeutics, Inc. Upgrade
PTC Therapeutics, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
MannKind Corp. Upgrade
Insmed, Inc. Upgrade